CHARLOTTE, N.C., Oct. 25, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced it will host a conference call to discuss its Byte Aligner business. Dentsply Sirona’s management team will host an investor conference call and live webcast on October 25, 2024, at 9:00 am ET. For those planning to participate on the call, please register at https://register.vevent.com/register/BI91fb506c8c2944bca6e65629062dd357. A webcast replay of the conference call ...

Voluntarily Suspends Sales and Marketing of Byte Aligners and Impression Kits Provides Select Preliminary Third Quarter 2024 Results CHARLOTTE, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), today announced the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products. The Company’s decision was made in consultation wit ...

The report shows strong overall progress against its goals for the fourth year in a row as well as several goals met ahead of their 2025 timeframe. Guided by its sustainability strategy "BEYOND: Taking Action for a Brighter World", Dentsply Sirona has achieved positive impact along its three pillars: Healthy Planet (environmental goals), Healthy Smiles (social goals) and Healthy Business (governance goals). Highlights from the 2023 Sustainability Report include but are not limited to: Significant reduction ...

DENTSPLY SIRONA (XRAY) is well-poised for growth on a robust product portfolio and continued focus on research and development. However, forex remains a concern. Shares of this Zacks Rank #3 (Hold) company have lost 24% year to date against the industry's 0.3% growth. The S&P 500 Index has gained 20.5% in the same time frame. XRAY, with a market capitalization of $5.41 billion, is a global leader in the design, development, manufacturing and marketing of dental consumables, dental laboratory products, denta ...

DENTSPLY SIRONA Inc. (XRAY) recently introduced a new, versatile and innovative intraoral scanner, Primescan 2. The new wireless scanner, powered by the DS Core cloud platform, is cloud-native and can scan on any Internet-connected mobile or desktop device without the need for a dedicated computer. Compared to Primescan AC and Primescan Connect, Primescan 2 is likely to help medical practitioners expand their treatment offerings, save time in daily workflows, and deliver enhanced care and comfort to their p ...

Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Brazil Digital Dentistry Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Dental CAD/CAM Devices, Dental CAD/CAM Materials (Discs & Blocks), Dental 3D Printers, and 2 more" report has been added to ResearchAndMarkets.com's offering. In 2023, the Brazilian digital dentistry market was valued at nearly $462 million. It is expected to grow at a CAGR of 2.9%, reaching over $564 million by the end of the forecast period. The comprehensive repo ...

CHARLOTTE, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced that Executive Vice President and Chief Financial Officer Glenn Coleman will resign effective November 7, 2024, to assume an executive position at another public company. The Company has initiated a search process to identify its next CFO with the assistance of a leading executive search firm. "On behalf of the entire Dentsply Sirona team, I want to extend our deepest g ...

: -2.3% versus the five-analyst average estimate of -1.9%. : $237 million versus the three-analyst average estimate of $237.47 million. The reported number represents a year-over-year change of -9.9%. : $253 million versus the five-analyst average estimate of $280.38 million. : $375 million versus $363.57 million estimated by five analysts on average. : $3 million versus $22.42 million estimated by two analysts on average. : $42 million compared to the $44.93 million average estimate based on two analysts. ...

Q2 24 Summary Results (GAAP) • Net sales of $984 million decreased (4.2%), organic sales decreased (2.3%) • GAAP gross margin of 51.9%, GAAP net loss of ($4) million or loss per share of ($0.02) • Adjusted EBITDA margin of 17.5%, adjusted EPS of $0.49 • Revised FY24 outlook: organic sales down (1%) to flat (previously flat to up 1.5%); adjusted EPS of $1.96 to $2.02 (previously $2.00 to $2.10) • Company repurchased $150 million of its common stock in Q2 2024; expects to repurchase $100 million of its common ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16211 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607 (Address of principal executive offices) (Zip Code) (844) 848-0137 (Registrant's telephone number, including area code) Indicate by check mark whether the re ...